Is Eloxx Pharmaceuticals, Inc. overvalued?

Eloxx Pharmaceuticals, Inc. (ELOX) — key valuation metrics and fundamentals.

No verdict

Price

$13.15

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$45.2M

Dividend yield

0.0%

Return on equity

-42.5%

Sector

Healthcare

Fair value compares ELOX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks